Endocrine therapy options currently include ovarian suppression along with three main classes of drugs: the selective estrogen receptor modulators (tamoxifen and toremifene), an estrogen receptor antagonist (fulvestrant), and the aromatase inhibitors (letrozole, anastrozole, and exemestane). Learn how the specific choice of therapy depends upon the stage of disease, prior therapy, and the menopausal status of the patient. By the session’s end, you’ll have gained a thorough understanding of endocrine therapy, the backbone of hormone receptor positive breast cancer therapy.
Objectives1. Understand the emerging treatment options, including endocrine therapy, for breast cancer.
2. Describe the implications of these treatment options for nursing practice.
ILNA
This session qualifies for the following ONCC Individual Learning Needs Assessment (ILNA) categories.
OCN®: Treatment Modalities
CBCN®: Treatment Modalities: Local and Systemic
AOCNP®: Cancer Treatment
AOCNS®: Cancer Treatment
